uptake rate up to 330 Ϯ 39 and 224 Ϯ 6 nM/s, respectively. Aldosterone also potentiated glucagon-and AVP-induced intracellular cAMP accumulation in a concentration-independent manner. As cAMP stimulates Mg 2ϩ entry in MDCT cells, it is inferred that aldosterone may stimulate Mg 2ϩ uptake through intracellular signaling pathways involving cAMP. The actions of aldosterone were dependent on de novo protein synthesis, as pretreatment of the cells with cycloheximide inhibited aldosterone potentiation of hormone stimulation of Mg 2ϩ uptake and cAMP accumulation. These studies with MDCT cells suggest that aldosterone may modulate the effects of hormones acting within the distal convoluted tubule to control magnesium absorption. intracellular magnesium; fluorescence; glucagon; arginine vasopressin; adenosine 3Ј,5Ј-cyclic monophosphate
intracellular magnesium; fluorescence; glucagon; arginine vasopressin; adenosine 3Ј,5Ј-cyclic monophosphate THE DISTAL TUBULE of the nephron normally reabsorbs ϳ10% of the filtered magnesium (23) . As there is little or no magnesium beyond the distal tubule, this segment is important in determining renal magnesium balance. Magnesium absorption within this nephron segment is influenced by a number of hormones including glucagon and arginine vasopressin (AVP) (23) . Using an immortalized mouse distal convoluted cell (MDCT) line, we have shown that glucagon and AVP stimulates Mg 2ϩ uptake, suggesting that among the segments composing the distal tubule, the convoluted portion is a site of hormone action (2) . The distal convoluted segment also possesses mineralocorticoid receptors (7, 9, 10, 15) . Although there is some dispute concerning their functional purpose within this segment (14, 21) , there is evidence that mineralocorticoid hormones enhance the expression of both Na ϩ conductance and NaCl cotransport in distal convoluted tubule cells (1, 27) . Accordingly, mineralocorticoids may alter Mg 2ϩ entry by acting through changes in ionic transport (4) . Alternatively, mineralocorticoids may affect hormone-mediated control of Mg 2ϩ transport within the distal tubule. Doucet et al. (6) have shown that adrenalectomy reduced glucagon-stimulated adenylate cyclase activity in thick ascending limbs; this reduced cAMP response was prevented with aldosterone administration (6) . Other investigators have shown that AVPsensitive adenylate cyclase is diminished in rat and rabbit collecting tubules harvested from adrenalectomized animals (8, 13, 20, 26) . Accordingly, mineralocorticoids could alter hormonal control of transport in the distal tubule through its actions on receptor-mediated signaling pathways.
In an accompanying report (2), we reported that glucagon and AVP increases cAMP accumulation in MDCT cells. As cAMP also stimulates Mg 2ϩ entry, these hormones may act, in part, through cAMP-mediated responses. It was therefore of interest to examine the effects of aldosterone on Mg 2ϩ transport in distal convoluted tubule cells and the interactions with hormonestimulated Mg 2ϩ uptake. In the present studies, it was shown that aldosterone potentiates glucagon-and AVPstimulated intracellular cAMP accumulation and Mg 2ϩ uptake in MDCT cells. The potentiation of hormone actions by mineralocorticoids may have significant effects on renal magnesium balance.
METHODS
Materials. Basal Dulbecco's minimal essential medium (DMEM) and Ham's F-12 media were purchased from GIBCO. Customized Mg 2ϩ -free media were purchased from Stem Cell Technologies (Vancouver, BC, Canada). Fetal calf serum was from Flow Laboratories (McLean, VA). Mag-fura 2-AM was obtained from Molecular Probes (Eugene, OR). Glucagon, AVP, aldosterone, and other materials were from Sigma Chemical (St. Louis, MO).
Cell culture. Distal convoluted tubule cells were isolated from mice, immortalized, and characterized as previously described (12, 17) . The MDCT cell line was grown on 60-mm plastic culture dishes (Corning Glass Works, Corning Medical and Scientific, Corning, NY) in DMEM-F12 (1:1) media supplemented with 10% fetal calf serum, 1 mM glucose, 5 mM L-glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin in a humidified environment of 5% CO 2 -95% air at 37°C. For the fluorescence studies, confluent cells were washed three times with phosphate-buffered saline containing 5 mM ethylene glycol-bis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid, trypsinized, and seeded on glass coverslips. Aliquots of harvested cells were allowed to settle onto sterile glass coverslips in 100-mm Corning tissue culture dishes, and the cells were grown to subconfluence over 1-2 days in supplemented media as described above. The normal media contained 0.6 mM Mg 2ϩ and 1.0 mM Ca 2ϩ . In the experiments indicated, the cells were cultured in Mg 2ϩ -free media (Ͻ0.01 mM) for 16-24 h prior to study. Other constituents of the Mg 2ϩ -free were similar to the complete media. The Mg 2ϩ -free media contained 0.2% bovine serum albumin rather than fetal calf serum.
Cytosolic Mg 2ϩ measurements. Coverslips were mounted into a perfusion chamber, and intracellular free Mg 2ϩ concentration ([Mg 2ϩ ] i ) was determined with the use of the Mg 2ϩ -sensitive fluorescent dye, mag-fura 2 (18) . The cell-permeant acetoxymethyl ester (AM) form of the dye was dissolved in dimethyl sulfoxide to a stock concentration of 5 mM and then diluted to 5 µM mag-fura 2-AM in media for 20 min at 23°C. Cells were subsequently washed three times with buffered salt solution containing (in mM) 145 NaCl, 4.0 KCl, 0.8 K 2 HPO 4 , 0.2 KH 2 PO 4 , 1.0 CaCl 2 , 5 glucose, and 20 N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid-tris(hydroxymethyl)aminomethane (HEPES-Tris), at pH 7.4. The MDCT cells were incubated for a further 20 min to allow for complete deesterfication and washed once before measurement of fluorescence.
Epifluorescence microscopy was used to monitor changes in the mag-fura 2 fluorescence of the MDCT cells. The chamber was mounted on an inverted Nikon Diaphot-TMD microscope, with a Fluor ϫ100 objective, and fluorescence was monitored under oil immersion within a single cell over the course of study. Fluorescence was recorded at 1-s intervals using a dual-excitation wavelength spectrofluorometer (Deltascan; Photon Technologies, Princeton, NJ) with excitation at 335 and 385 nm (chopper speed set at 100 Hz/s) and emission at 505 nm. All experiments were performed at 23°C. Solution changes were made without an interruption in recording.
The [Mg 2ϩ ] i was calculated from the ratio of the fluorescence at the two excitation wavelengths as described using a dissociation constant (K d ) of 1.4 mM for the mag-fura 2 · Mg 2ϩ complex (18) . The minimum (R min ) and maximum (R max ) ratios were determined for the cells at the end of each experiment using 20 µM digitonin. R max for mag-fura 2 was found by the addition of 50 mM MgCl 2 in the absence of Ca 2ϩ , and R min was obtained by removal of Mg 2ϩ and addition of 100 mM EDTA, pH 7.2.
Determination of intracellular cAMP concentrations. cAMP was determined in confluent MDCT cell monolayers cultured in 24-well plates in DMEM-F12 media without fetal calf serum. After addition of various hormones, MDCT cells were incubated at 37°C for 5 min in the presence of 0.1 mM 3-isobutyl-1-methylxanthine. The cAMP was extracted with 5% trichloroacetic acid and further extracted with ether acidified with 0.1 N HCl. The aqueous phase was dried and dissolved in Tris-EDTA buffer, and cAMP was measured with a radioimmunoassay kit (Diagnostic Products, Los Angeles, CA).
Statistical analysis. Representative tracings of fluorescence intensities are given, and significance was determined by Tukey's analysis of variance. A probability of P Ͻ 0.05 was taken to be statistically significant. All results are means Ϯ SE where indicated. In an accompanying report (2), we have shown that glucagon and AVP stimulate Mg 2ϩ uptake into Mg 2ϩ -depleted MDCT cells in a concentration-dependent fashion. Maximal concentration of glucagon, 10 Ϫ6 M, and AVP, 3 ϫ 10 Ϫ7 M, enhanced mean Mg 2ϩ uptake rates by 273 Ϯ 6 and 189 Ϯ 6 nM/s, respectively. Hormone-stimulated uptake was inhibited by nifedipine and was not affected by pretreatment with the protein synthesis inhibitor, cycloheximide. It was concluded that hormonal actions were through activation of putative Mg 2ϩ channels that was independent of de novo protein synthesis.
RESULTS

Mg
Aldosterone potentiates hormone-stimulated Mg 2ϩ uptake. Next, we determined the effects of mineralocorticoids on Mg 2ϩ entry into distal convoluted tubule cells. The addition of aldosterone, 10 Ϫ7 M, 20 min prior to the measurement of Mg 2ϩ entry did not alter the rate of Mg 2ϩ uptake (189 Ϯ 21 nM/s, n ϭ 3). Incubation of MDCT cells with aldosterone, 10 Ϫ7 M, for 16 h prior to determination of Mg 2ϩ entry also had no effect on basal Mg 2ϩ uptake (172 Ϯ 8 nM/s, n ϭ 3). However, pretreatment of MDCT cells with aldosterone potentiated both glucagon-and AVP-stimulated Mg 2ϩ uptake rates (Fig.  1) . Hormone-stimulated Mg 2ϩ refill was enhanced with aldosterone, but aldosterone treatment had no effect on the final [Mg 2ϩ ] i attained following refill; this first concentration was not different from control values (0.52 mM). Furthermore, aldosterone potentiated glucagon and AVP at all hormone concentrations above 10 Ϫ9 M (Figs. 2 and 3) . The glucagon concentration required to produce half-maximal stimulation of Mg 2ϩ uptake in aldosterone-treated cells was ϳ5 ϫ 10 Ϫ7 M, which was not different from control cells. Unlike glucagon, AVP stimulates Mg 2ϩ uptake after a latent period of 5-10 min (Fig. 1B) . Pretreatment of cells with aldosterone appeared to shorten the duration of this latent period (Fig. 1B) . The AVP concentrations for half-maximal stimulated Mg 2ϩ uptake was not changed (Fig. 3) .
Mg 2ϩ uptake in MDCT cells is sensitive to the dihydropyridine channel blockers such as nifedipine (4) . Nifedipine also blocks glucagon-and AVP-stimulated Mg 2ϩ entry (2). Accordingly, if aldosterone potentiation activates hormone-stimulated uptake through these pathways, then nifedipine should block this response. Figure 4 shows that aldosterone-potentiated, hormone-stimulated Mg 2ϩ uptake is sensitive to nifedipine, suggesting that Mg 2ϩ entry is being affected.
Aldosterone potentiates hormone-stimulated cAMP accumulation in MDCT cells. Evidence has been given that mineralocorticoids may increase the coupling effi- http://ajprenal.physiology.org/ ciency of hormone receptors through G proteins to adenylate cyclase (6) . Accordingly, we determined hormone-stimulated cAMP release in MDCT cells pretreated with aldosterone. Aldosterone did not have any effect on basal cAMP concentrations in control cells (Table 1) . However, aldosterone potentiated cAMP accumulation in response to glucagon and AVP. Aldosterone also enhanced cAMP release by parathyroid hormone and calcitonin; accordingly, potentiation of hormonemediated cAMP production by mineralocorticoids may be a general phenomenon (Table 1) . These results indicate that mineralocorticoids increase receptormediated cAMP release, which may provide the basis for potentiation of Mg 2ϩ uptake in MDCT cells.
Aldosterone potentiates glucagon-stimulated cAMP release in a concentration-dependent manner (Fig. 5) . Incubation of cells for 16 h with various aldosterone concentrations potentiated maximal glucagon responses with a half-maximal aldosterone concentration at ϳ10 Ϫ8 M.
Aldosterone potentiates hormone-stimulated Mg 2ϩ uptake and cAMP generation through de novo protein synthesis. As it has been well established that mineralocorticoids act, in part, through translational processes, we tested whether potentiation of hormone action may be through induced proteins. In this study, we Mg 2ϩ depleted the MDCT cells for 16 h prior to the addition of aldosterone with and without cycloheximide. The cells were incubated for a further 3 h, and fluorescence measurements were performed in the presence of 1.5 mM MgCl 2 to determine Mg 2ϩ uptake. Mg 2ϩ uptake was 244 Ϯ 14 nM/s in the presence of aldosterone plus glucagon. Addition of cycloheximide with aldosterone, 3 h prior to fluorescence determination, resulted in the inhibition of aldosterone potentiation of glucagonstimulated Mg 2ϩ entry (Table 2) . Cycloheximide did not have any effect on glucagon-stimulated Mg 2ϩ entry in the absence of mineralocorticoids ( Table 2 ). These observations indicate that aldosterone may potentiate hormone actions through mechanisms dependent on de novo protein synthesis.
Next, we determined the effect of cycloheximide on aldosterone potentiation of hormone-stimulated cAMP accumulation. Again, the cells were Mg 2ϩ depleted for 16 h, then treated with aldosterone, 10 Ϫ7 M, with and without cycloheximide. Three hours later, hormoneresponsive cAMP release was determined by radioimmunoassay measurements. Glucagon, 10 Ϫ7 M, stimulated cAMP release from 19 Ϯ 1 to 105 Ϯ 5 pmol · mg protein Ϫ1 · 5 min Ϫ1 (Table 1) . Cycloheximide pretreatment did not alter cAMP generation. However, cycloheximide prevented the potentiation of aldosterone-or glucagon-induced cAMP release (Table 2) .
DISCUSSION
Mineralocorticoid receptors are present in distal convoluted tubule cells, which are thought to be involved in enhanced expression of NaCl cotransport, Na ϩ conductance, and sodium pump activity (1, 7, 9, 10, 15, 21, 25) . Reports of the effects of adrenal steroids on renal magnesium conservation are equivocal (reviewed in Refs. 16 and 19) . On balance, acute administration of aldosterone has little or no effect on renal magnesium conservation, whereas chronic hyperaldosteronism is associated with renal magnesium wasting (16) . The latter has been explained by mineralocorticoid-induced volume expansion leading to diminished proximal and loop magnesium reabsorption. Alternatively or in conjunction with volume expansion, cellular potassium depletion may provide the basis of renal magnesium wasting. We have shown that Mg 2ϩ entry into potassium-depleted MDCT cells is significantly diminished compared with control cells (3) . Alteration of sodium absorption in the distal tubule may also affect Mg 2ϩ transport in this segment. The present studies suggest that aldosterone may have little effect on distal Mg 2ϩ transport by itself but potentiates the actions of magnesium-conserving hormones, such as glucagon and AVP. Glucagon-and AVP-stimulated Mg 2ϩ entry was greater in MDCT cells pretreated with aldosterone relative to control values (Fig. 1) . These actions may be through an augmentation of hormone-mediated signaling pathways.
A number of studies have shown that mineralocorticoids enhance hormone-stimulated cAMP generation. Adrenal insufficiency is associated with impairment of urinary diluting and concentrating capacity (13, 26; reviewed in Ref. 6 ). Rajerison et al. (20) demonstrated that adrenalectomy reduced AVP-stimulated adenylate cyclase activity in membrane fractions prepared from rat kidney medulla. Doucet et al. (6) have shown that glucagon-, calcitonin-, and AVP-responsive adenylate cyclase activity is diminished in thick ascending limb and collecting tubule segments harvested from adrenalectomized rats compared with animals treated with aldosterone (6). They used segments within 2.5 h (8). These workers postulate that aldosterone induces a protein(s) that stimulates hormone-sensitive adenylate cyclase activity. Their studies with kidney membrane fractions and isolated segments demonstrated that an improvement of coupling between hormone receptors and adenyl cyclase catalytic units was responsible for enhanced cAMP generation in the presence of aldosterone (8) . The mechanism(s) through which steroids control G s proteins (synthesis and/or degradation vs. activity of each unit) is not known (6) . Mineralocorticoids may also increase the number of hormone receptors expressed on the cell surface, thereby amplifying hormonal actions. The present studies suggest that aldosterone potentiates glucagon-and AVP-stimulated cAMP generation in distal convoluted tubule cells. This was associated with an increase in Mg 2ϩ entry rate in response to these hormones. We have previously shown that cAMP increases Mg 2ϩ uptake in MDCT cells; accordingly, aldosterone may enhance hormone-stimulated Mg 2ϩ entry by increases in hormone-mediated cAMP release or by amplification of cAMP-mediated actions (2) . As there is no association of Mg 2ϩ uptake rate with hormone-induced cAMP release, the latter actions may be valid (2) . Further research is warranted to determine the signaling pathways whereby hormones mediate the control of Mg 2ϩ transport.
Aldosterone potentiates AVP-stimulated Mg 2ϩ entry in MDCT cells. Although the physiological role of this response to AVP is not clear, stimulation of Mg 2ϩ reabsorption by AVP may be necessary to maintain normal Mg 2ϩ balance when salt and water flow in the distal tubule is reduced during antidiuresis. Mineralocorticoid potentiation would increase AVP-stimulated Mg 2ϩ reabsorption commensurate with enhanced salt and water retention. The importance of potentiation of glucagon effects is also not clear, but a similar rationale may hold as for AVP, because de Rouffignac (22) has postulated that a number of hormones including glucagon and AVP act in combination to maintain salt and water equilibrium. Accordingly, aldosterone potentiation of these hormones is associated with increased Mg 2ϩ conservation along with salt and water retention.
In summary, these studies show that aldosterone potentiates glucagon-and AVP-stimulated Mg 2ϩ uptake into MDCT cells. From these observations, we infer that mineralocorticoids may have important effects on hormone regulation of magnesium absorption within the distal convoluted tubule. Aldosterone acts through de novo protein synthesis on nifedipinesensitive pathways. However, the intracellular pathways involved in stimulation of Mg 2ϩ uptake remain to be described.
